1. |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
|
2. |
Zhang J, Liu X, Huang Z, et al. T cell-related prognostic risk model and tumor immune environment modulation in lung adenocarcinoma based on single-cell and bulk RNA sequencing. Comput Biol Med, 2023, 152: 106460.
|
3. |
Song P, Li W, Guo L, et al. Identification and validation of a novel signature based on NK cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinoma by integrated analysis of single-cell and bulk RNA-Sequencing. Front Immunol, 2022, 13: 850745.
|
4. |
Lane JM, Qian J, Mignot E, et al. Genetics of circadian rhythms and sleep in human health and disease. Nat Rev Genet, 2023, 24(1): 4-20.
|
5. |
Wang Z, Su G, Dai Z, et al. Circadian clock genes promote glioma progression by affecting tumour immune infiltration and tumour cell proliferation. Cell Prolif, 2021, 54(3): e12988.
|
6. |
Salamanca-Fernández E, Rodríguez-Barranco M, Guevara M, et al. Night-shift work and breast and prostate cancer risk: Updating the evidence from epidemiological studies. An Sist Sanit Navar, 2018, 41(2): 211-226.
|
7. |
Papantoniou K, Devore EE, Massa J, et al. Rotating night shift work and colorectal cancer risk in the nurses' health studies. Int J Cancer, 2018, 143(11): 2709-2717.
|
8. |
徐嘉昕, 钱凯, 蒋立虹. 机器学习算法在肺癌临床诊断及生存预后分析中的应用. 中国胸心血管外科临床杂志, 2022, 29(6): 777-781.Xu JX, Qian K, Jiang LH. Application of machine learning algorithm in clinical diagnosis and survival prognosis analysis of lung cancer. Chin J Clin Thorac Cardiovasc Surg, 2022, 29(6): 777-781.
|
9. |
Li Y, Wang J, Wang F, et al. Identification of specific cell subpopulations and marker genes in ovarian cancer using single-cell RNA sequencing. Biomed Res Int, 2021, 2021: 1005793.
|
10. |
Liang L, Yu J, Li J, et al. Integration of scRNA-Seq and bulk RNA-seq to analyse the heterogeneity of ovarian cancer immune cells and establish a molecular risk model. Front Oncol, 2021, 11: 711020.
|
11. |
Szklarczyk D, Gable AL, Nastou KC, et al. The STRING database in 2021: Customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res, 2021, 49(D1): D605-D612.
|
12. |
Shen H, Gu X, Li H, et al. Exploring prognosis, tumor microenvironment and tumor immune infiltration in hepatocellular carcinoma based on ATF/CREB transcription factor family gene-related model. J Hepatocell Carcinoma, 2023, 10: 327-345.
|
13. |
Xiao S, Zhou Y, Wu Q, et al. FCER1G and PTGS2 serve as potential diagnostic biomarkers of acute myocardial infarction based on integrated bioinformatics analyses. DNA Cell Biol, 2021, 40(8): 1064-1075.
|
14. |
Qiu BQ, Lin XH, Lai SQ, et al. ITGB1-DT/ARNTL2 axis may be a novel biomarker in lung adenocarcinoma: A bioinformatics analysis and experimental validation. Cancer Cell Int, 2021, 21(1): 665.
|
15. |
Song C, Wu Z, Wang Q, et al. A combined two-mRNA signature associated with PD-L1 and tumor mutational burden for prognosis of lung adenocarcinoma. Front Cell Dev Biol, 2021, 9: 634697.
|
16. |
Xue T, Chen Y, Xu J, et al. Cyclovirobuxine D inhibits growth and progression of non-small cell lung cancer cells by suppressing the KIF11-CDC25C-CDK1-CyclinB1 G2/M phase transition regulatory network and the NFκB/JNK signaling pathway. Int J Oncol, 2023, 62(5): 57.
|
17. |
Zhang H, Shan G, Jin X, et al. ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinoma. Transl Oncol, 2022, 26: 101562.
|
18. |
Xian H, Li Y, Zou B, et al. Identification of TIMELESS and RORA as key clock molecules of non-small cell lung cancer and the comprehensive analysis. BMC Cancer, 2022, 22(1): 107.
|
19. |
Zhang S, Huang P, Dai H, et al. TIMELESS regulates sphingolipid metabolism and tumor cell growth through Sp1/ACER2/S1P axis in ER-positive breast cancer. Cell Death Dis, 2020, 11(10): 892.
|
20. |
Yuan W, Fang W, Zhang R, et al. Therapeutic strategies targeting AMPK-dependent autophagy in cancer cells. Biochim Biophys Acta Mol Cell Res, 2023, 1870(7): 119537.
|
21. |
Ben-Jonathan N, Borcherding DC, Hugo ER. Dopamine receptors in breast cancer: Prevalence, signaling, and therapeutic applications. Crit Rev Oncog, 2022, 27(2): 51-71.
|
22. |
Owen KL, Brockwell NK, Parker BS. JAK-STAT signaling: A double-edged sword of immune regulation and cancer progression. Cancers (Basel), 2019, 11(12): 2002.
|
23. |
Baratchian M, Tiwari R, Khalighi S, et al. H3K9 methylation drives resistance to androgen receptor-antagonist therapy in prostate cancer. Proc Natl Acad Sci U S A, 2022, 119(21): e2114324119.
|
24. |
Li Z, Sillanpää MJ. Overview of LASSO-related penalized regression methods for quantitative trait mapping and genomic selection. Theor Appl Genet, 2012, 125(3): 419-435.
|
25. |
Huang ML, Hung YH, Lee WM, et al. SVM-RFE based feature selection and Taguchi parameters optimization for multiclass SVM classifier. Sci World J, 2014, 2014: 795624.
|
26. |
Blanchet L, Vitale R, van Vorstenbosch R, et al. Constructing bi-plots for random forest: Tutorial. Anal Chim Acta, 2020, 1131: 146-155.
|
27. |
Li F, Zhou Y, Zhang Y, et al. POSREG: Proteomic signature discovered by simultaneously optimizing its reproducibility and generalizability. Brief Bioinform, 2022, 23(2): bbac040.
|
28. |
Zhou Y, Liu C, Zhang Z, et al. Identification and validation of diagnostic biomarkers of coronary artery disease progression in type 1 diabetes via integrated computational and bioinformatics strategies. Comput Biol Med, 2023, 159: 106940.
|
29. |
Timmons GA, O'Siorain JR, Kennedy OD, et al. Innate rhythms: Clocks at the center of monocyte and macrophage function. Front Immunol, 2020, 11: 1743.
|
30. |
Aiello I, Fedele MLM, Román F, et al. Circadian disruption promotes tumor-immune microenvironment remodeling favoring tumor cell proliferation. Sci Adv, 2020, 6(42): eaaz4530.
|
31. |
Filipowska J, Kondegowda NG, Leon-Rivera N, et al. LGR4, a G protein-coupled receptor with a systemic role: From development to metabolic regulation. Front Endocrinol (Lausanne), 2022, 13: 867001.
|
32. |
Ordaz-Ramos A, Rosales-Gallegos VH, Melendez-Zajgla J, et al. The role of LGR4 (GPR48) in normal and cancer processes. Int J Mol Sci, 2021, 22(9): 4690.
|
33. |
Zha LF, Zhang LD, Pan HM, et al. Upregulation of lncRNA NCK1-AS1 predicts poor prognosis and contributes to non-small cell lung cancer proliferation by regulating CDK1. Eur Rev Med Pharmacol Sci, 2021, 25(3): 1351-1357.
|
34. |
Xue J, Song Y, Xu W, et al. The CDK1-related lncRNA and CXCL8 mediated immune resistance in lung adenocarcinoma. Cells, 2022, 11(17): 2688.
|
35. |
Luo HY, Zhu JY, Chen M, et al. Krüppel-like factor 10 (KLF10) as a critical signaling mediator: Versatile functions in physiological and pathophysiological processes. Genes Dis, 2022, 10(3): 915-930.
|
36. |
Taracha-Wisniewska A, Kotarba G, Dworkin S, et al. Recent discoveries on the involvement of Krüppel-like factor 4 in the most common cancer types. Int J Mol Sci, 2020, 21(22): 8843.
|
37. |
Zhang J, Li G, Feng L, et al. Krüppel-like factors in breast cancer: Function, regulation and clinical relevance. Biomed Pharmacother, 2020, 123: 109778.
|
38. |
Xiao W, Geng W, Zhou M, et al. POU6F1 cooperates with RORA to suppress the proliferation of lung adenocarcinoma by downregulation HIF1A signaling pathway. Cell Death Dis, 2022, 13(5): 427.
|
39. |
Morales-Santana S, Morell S, Leon J, et al. An overview of the polymorphisms of circadian genes associated with endocrine cancer. Front Endocrinol (Lausanne), 2019, 10: 104.
|
40. |
Ma X, Chen H, Li L, et al. CircGSK3B promotes RORA expression and suppresses gastric cancer progression through the prevention of EZH2 trans-inhibition. J Exp Clin Cancer Res, 2021, 40(1): 330.
|
41. |
Du H, Mu R, Liu L, et al. Single nucleotide polymorphisms in FOXP1 and RORA of the lymphocyte activation-related pathway affect survival of lung cancer patients. Transl Lung Cancer Res, 2022, 11(5): 890-901.
|
42. |
Zhang Z, Liang Z, Gao W, et al. Identification of circadian clock genes as regulators of immune infiltration in hepatocellular carcinoma. J Cancer, 2022, 13(11): 3199-3208.
|
43. |
Tang X, Qi C, Zhou H, et al. A novel metabolic-immune related signature predicts prognosis and immunotherapy response in lung adenocarcinoma. Heliyon, 2022, 8(8): e10164.
|
44. |
Yao R, Zhou L, Guo Z, et al. Integrative molecular analyses of an individual transcription factor-based genomic model for lung cancer prognosis. Dis Markers, 2021, 2021: 5125643.
|
45. |
He LP, Chen YF, Yang J. Investigation on the role and mechanism of prostagland in D2 synthase in non-small cell lung cancer. Zhonghua Yi Xue Za Zhi, 2017, 97(38): 3022-3027.
|
46. |
Liu Y, Guo S, Sun Y, et al. CRS: A circadian rhythm score model for predicting prognosis and treatment response in cancer patients. J Transl Med, 2023, 21(1): 185.
|
47. |
Benna C, Rajendran S, Spiro G, et al. Gender-specific associations between polymorphisms of the circadian gene RORA and cutaneous melanoma susceptibility. J Transl Med, 2021, 19(1): 57.
|
48. |
Ruberto AA, Gréchez-Cassiau A, Guérin S, et al. KLF10 integrates circadian timing and sugar signaling to coordinate hepatic metabolism. Elife, 2021, 10: e65574.
|
49. |
Mattiola I, Pesant M, Tentorio PF, et al. Priming of human resting NK cells by autologous M1 macrophages via the engagement of IL-1β, IFN-β, and IL-15 Pathways. J Immunol, 2015, 195(6): 2818-2828.
|
50. |
Zeng X, Liang C, Yao J. Chronic shift-lag promotes NK cell ageing and impairs immunosurveillance in mice by decreasing the expression of CD122. J Cell Mol Med, 2020, 24(24): 14583-14595.
|